Acadia Pharmaceuticals Inc (0A4W)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -69.317 | -61.207 | -53.031 | -35.554 | -35.967 | -22.643 | -33.538 | -9.169 |
Return on Equity (%) | -75.579 | -67.8 | -60.217 | -39.935 | -42.467 | -28.747 | -45.888 | -14.729 |
Return on Invested Capital (%) | -76.485 | -68.888 | -61.301 | -42.208 | -43.586 | -29.653 | -49.87 | -20.065 |
Operating Margin (%) | -1558.202 | -230.81 | -108.994 | -69.124 | -63.604 | -34.601 | -41.266 | -7.026 |
Net Profit Margin (%) | -1565.94 | -231.706 | -109.555 | -69.382 | -63.742 | -34.673 | -41.756 | -8.437 |
Book Value Per Share | 4.214 | 2.65 | 3.302 | 4.486 | 3.921 | 3.359 | 2.471 | 2.231 |
Earnings Per Share | -2.236 | -2.326 | -1.704 | -1.515 | -1.764 | -1.043 | -1.333 | -0.373 |
Cash Per Share | 1.348 | 0.558 | 0.937 | 1.222 | 2.042 | 0.916 | 0.709 | 1.149 |
Working Capital Per Share | 4.164 | 2.608 | 3.243 | 4.414 | 3.831 | 3.24 | 2.359 | 2.204 |
Operating Profit Per Share | 0.133 | 0.953 | 1.491 | 2.128 | 2.722 | 2.96 | 3.141 | 4.205 |
EBIT Per Share | -2.225 | -2.317 | -1.696 | -1.509 | -1.76 | -1.04 | -1.317 | -0.311 |
EBITDA Per Share | -2.225 | -2.317 | -1.696 | -1.509 | -1.76 | -1.04 | -1.317 | -0.311 |
Free Cash Flow Per Share | -2.239 | -2.341 | -1.71 | -1.526 | -1.735 | -1.056 | -1.345 | -0.163 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 121,37M | 124,41M | 143,85M | 155,28M | 159,64M | 161,01M | 162,06M | N/A |
Capitalisation boursière | 0 |
Ratio cours/bénéfice | -46,64 |
Ratio prix/ventes | 3,93 |
Ratio prix/liquidités | 15,15 |
Ratio prix/valeur comptable | 6,62 |
Rendement de dividende | - |
Actions en circulation | 164,18M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales